UK markets open in 6 hours 11 minutes

Orphazyme A/S (0CUM.L)

LSE - LSE Delayed price. Currency in DKK
Add to watchlist
0.9860-0.2660 (-21.25%)
At close: 10:07AM BST
Full screen
Previous close1.2520
Open0.0000
Bid0.0000 x N/A
Ask0.0000 x N/A
Day's range0.0000 - 0.0000
52-week range
Volume2,067
Avg. volume85
Market capN/A
Beta (5Y monthly)0.16
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
All
News
  • Globe Newswire

    Change in management

    The board of directors and CEO/CFO Anders Fink Vadsholt has today entered into a severance agreement pursuant to which Mr. Vadsholt will step down as CEO/CFO of the Company. Regardless, Mr. Vadsholt will remain available for the company until his replacement has been found and all disputes related to the US security class action case has been finally settled, however, in no event longer than until 1 October 2023. Anders Fink Vadsholt states:” With the latest progress in our US security class act